DIABETES NEWS
Novo Nordisk to discontinue Human Mixtard, India's largest selling insulin brand
Novo Nordisk will discontinue Human Mixtard, a top-selling insulin in India. This decision aligns with the company's global strategy. They will prioritize newer, patented therapies like Ozempic and Wegovy. The company plans to introduce these therapies in India this year. While vials will still be available, pen devices, preferred by many, may become less accessible.
Shedding weight may no longer be a prickly issue as Eli Lilly’s weight-loss pill moves closer to launch
Eli Lilly's new oral weight-loss pill, orforglipron, shows promise in late-stage trials across countries like India and the US. Participants experienced an average weight loss of 7.2 kg with the 36 mg dose over 40 weeks. While less potent than injectable Wegovy, orforglipron offers a needle-free alternative, potentially easing distribution, especially in emerging markets.
US stock market outlook April 17: Dow drops as UnitedHealth sinks; S&P 500, Nasdaq edge up with Eli Lilly, TSMC gains; Nvidia hit by $5.5B China export blow
US stock market outlook April 17: S&P 500 futures rise as Wall Street reacts to mixed earnings and Fed comments. While Dow futures fall 583 points dragged by UnitedHealth’s 19% plunge, the S&P 500 and Nasdaq-100 managed slight gains, thanks to Eli Lilly's 13% surge on weight-loss drug trial success and Taiwan Semiconductor’s 3% jump after strong AI chip demand. Meanwhile, Nvidia’s $5.5B charge over U.S. export restrictions to China adds pressure on tech stocks. Fed Chair Powell’s warning on tariffs fueling inflation stirred fears of stagflation. Investors remain cautious heading into a long weekend with Good Friday market closure.
Gossip Girl star Michelle Trachtenberg’s cause of death revealed
Michelle Trachtenberg was found unresponsive at her apartment on February 26. The Gossip Girl star was later pronounced dead. As per reports, the actor died due to complications from diabetes mellitus.
It's time to protect America from America's President
Donald Trump's actions are testing American institutions. He is defying courts and undermining universities. The El Salvador president meeting raised concerns. The administration deported a man despite a judge's order. Critics compare Trump's actions to authoritarian regimes. Harvard is resisting Trump's demands. Funding cuts threaten medical research. These actions are vandalism of the American project. Voters must protect national greatness.
Type 5 Diabetes: The new health threat affecting millions of kids with this condition, here’s what every parent needs to know
The International Diabetes Federation (IDF) has officially recognized Type 5 diabetes, also known as Severe Insulin-Deficient Diabetes (SIDD), linked to malnutrition in teenagers and young adults, particularly in low- and middle-income countries. This distinct condition, prevalent in Asia and Africa, has been overlooked for decades and misdiagnosed as Type 1 or Type 2 diabetes.
- Go To Page 1
In major development in pharma, halt order enforced on production and sale of 35 fixed-dose combination drugs
India's drug regulator, CDSCO, has ordered a halt to the production, sale, and distribution of 35 fixed-dose combination (FDC) drugs due to safety concerns. These drugs, including pain relievers and diabetes medications, lacked proper evaluation before approval. The CDSCO has directed state and Union territory regulators to reassess approval procedures, ensuring adherence to the Drugs and Cosmetics Act.
Sweet Surrender: Sanofi puts star insulin brand Lantus up for sale, eyes Rs 2,000 cr from Indian pharma giants
Sanofi India is divesting its insulin brand, Lantus, with Glenmark, Dr. Reddy's, and Emcure Pharma considering acquisition, though a licensing agreement remains a possibility. The asking price has been reduced to ?2,000 cr due to declining sales and government price cuts. Despite newer insulin options, Lantus remains a market leader in India's growing diabetes market.
Woman loses 50kg without weight-loss drugs or injections after near-death wake-up call
Ree O’Reilly from Victoria faced a health crisis due to Type 2 diabetes. She survived sepsis and a near-death experience. Ree transformed her life through diet and determination. She lost 50kg by cutting processed foods. Ree reversed her diabetes and discontinued medications. Now, she inspires others with her health journey. She enjoys an active life with her fiancé, Bill.
While being bullish, just learn to tackle volatility: 6 mid-cap stocks from different sectors with an upside potential up to 49%
As the new financial year starts, we are set for more news about disruption caused by tariffs and their counter-measures. Don’t be surprised by the yo-yo-like movements of the Nifty and Sensex over the next couple of weeks. In fact, get used to it. There is a high probability that the volatility quotient of the market will in fact remain high for the next couple of months. But that does not mean that you cannot be bullish. But with a caveat: While buying stocks, focus on risk-management. When we say risk-management, don’t just focus on allocation of money. Focus also on the way you select a stock or a sector.
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 35%, according to analysts
After six months of cooling off, are valuations in the mid-cap segment fairly priced? The answer is, no. Does it mean you should avoid this segment? The answer is, again, no. Over the next few quarters, stock price trends and the absolute value of stock prices will be impacted by sectoral fundamentals as well as valuations. As an investor, keep an eye on liquidity and market breadth for the next few sessions as they will determine what happens to mid-cap stocks in the medium term. If both market breadth and the Nifty stay positive, it is likely that we will see more strength in the mid-cap segment. And that would probably also signal the end of this phase of correction.
What is a 'sedentary lifestyle'? Cardiologist warns that too much sitting may be as harmful as smoking
Leading cardiologists are warning about the dangers of a sedentary lifestyle, equating it to the health risks of smoking. Extended periods of sitting can increase the risk of heart disease, type 2 diabetes, and obesity. Simple daily activities like short walks and frequent breaks can significantly counteract these effects, highlighting the importance of regular movement.
Stocks in news: Vedanta, Bajaj Finserv, IndusInd Bank, Bank of Maharashtra, Triveni Engineering
Vedanta Chairman Anil Agarwal reaffirmed the company's commitment to unlocking value, saying the four new companies that will emerge from the demerger, have the potential to grow into $100 billion companies each.
Stevie Wonder announces Love, Light and Song UK tour; check dates, ticket details
Stevie Wonder will perform in Lytham, Manchester, Birmingham, Cardiff, and London this July, with a headline performance at the iconic American Express Presents BST Hyde Park Festival in London. Renowned for his exceptional musical talent, he is equally celebrated for his humanitarian efforts and significant contributions to various causes.
Stedman Pearson dies at 60: What singer's Five Star bandmate revealed about demise
Five Star had a string of hits, including Rain or Shine, which reached number two in the charts in 1986. The band was formed in 1983 by Stedman Pearson and his siblings Delroy, Lorraine, Deniece and Doris, and quickly became a household name for the siblings’ matching costumes and choreographed dance routines.
Who is Jay Bhattacharya, US' new National Institutes of Health director
Dr. Jay Bhattacharya, a Stanford professor against Covid lockdowns, is set for a Senate confirmation hearing to lead NIH. His nomination is contentious due to his unconventional background and Covid stance. Key topics will include funding cuts, staff reductions, and reforms linking research grants to academic freedom. Bhattacharya emphasizes creating a culture of scientific dissent.
Protecting your heart and managing diabetes: The power of a holistic lifestyle
Adopting a holistic lifestyle can significantly improve heart health and manage diabetes. Key strategies include a balanced diet, regular physical activity, stress management, maintaining healthy weight, and regular health check-ups. These habits are crucial for reducing the risk of heart disease and improving overall well-being.
Diabetes and obesity: The duo you need to break up with
World Obesity Day, observed on March 4th, emphasizes the dangers of the combined effects of diabetes and obesity, termed 'diabesity.' This harmful partnership increases the risk of severe health issues like heart disease, kidney damage, and nerve pain. The observance calls for lifestyle changes and medical interventions to manage and break free from diabesity's damaging cycle, promoting a healthier society.
Stocks in news: M&M, Glenmark Pharma, Tata Motors, IOB, Sun Pharma
Mahindra & Mahindra is working to scale up some of its smaller businesses to match its portfolio of multiple large companies, the top executive at the tractor-to-technology group told ET.
Taking charge of diabetes and heart health
Understanding Adiposity-Based Chronic Disease (ABCD) is crucial for managing the effects of obesity on diabetes and heart health. Focusing on belly fat reduction and maintaining healthy habits can significantly lower heart risks, improve blood pressure, cholesterol, and blood sugar levels. Consulting with a healthcare professional is essential.
Biocon launches diabetes, obesity management drug in UK
Biocon has launched Liraglutide, a drug for diabetes and obesity management, in the UK under the brand names Liraglutide Biocon and Biolide. This follows approval from the UK's MHRA, making Biocon the first generics company to gain such approval in a major regulated market.
Lillia unveils AI platform for chronic disease management
Lillia, an AI startup, has launched a platform to help manage diabetes and related chronic conditions using AI and expert human coaches. They've received a $1.7 million grant from QRDI Council for their digital twin technology, aiming to revolutionize chronic care through predictive capabilities and real-time interventions.
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 30%
The ongoing bearishness is exposing cracks in the stock market that the bulls had papered over with liquidity. This phase is thus a stress test not just for your investments, but also your decision-making abilities and comfort with risk. Most of us take maximum risk when it is time to avoid it; and sit back when it is time to increase it. Consider: Which is the better time to buy? September 2024, or today? Logically, today, because prices are down and valuations have cooled a bit. But as fear has taken over, it is extremely difficult to make a distinction between stock prices and the underlying businesses.
MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%
While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that having MNC stocks in your portfolio is an assurance of growth and returns no longer holds true. Once upon a time, owning MNC stocks, irrespective of the sector, was important as they were liberal with bonuses and dividends. Also, some of them owned the best brands which delivered secular growth, allowing them to be generous to shareholders. But maybe it is time to shed the bias against them, especially MNC pharma firms which have gone through restructuring.
Diabetes in India: Embracing a holistic perspective to combat a growing epidemic
Diabetes is a rising health issue in India, with millions affected by the disease and its precursors. Addressing lifestyle factors such as nutrition, fitness, stress, and sleep is crucial for effective diabetes management and prevention of complications. A holistic approach combining these elements can significantly improve health outcomes.
These foods should be avoided to check heart disease, diabetes, stroke, cancer, dementia
Cardiologist Dr. Aseem Malhotra warns that a poor diet promotes chronic diseases such as heart disease, diabetes, and strokes.
This New Year explore the ABCD of diabetes
Diabetes and heart health are influenced by A1C, body weight, cardiovascular health, and the duration of diabetes. Excess weight, especially around the waist, increases the risk for heart disease and makes diabetes management tougher. Losing 5-10% of body weight can significantly improve both heart and blood sugar levels. Small health changes now can have a big impact.
Diabetes, heart, and kidneys: The hidden links you can’t afford to ignore
Diabetes impacts not just blood sugar but also the heart and kidneys. High sugar levels strain these organs, causing complications. Regular checkups, healthy lifestyle choices, and weight management are vital for minimizing risks and managing health effectively. Early detection and personalized treatments can significantly improve outcomes for people with diabetes.
At over 10 cr, India’s diabetic population is surging, yet the country lags behind in prescribing new medicines
Priya Rao experienced confusion and worry after fainting and receiving different diabetic medications from two doctors. The first doctor followed global guidelines, while the second used Indian ones, stabilizing her condition. The case underscores different diabetic treatment protocols and the importance of tailored patient care in India.
Load More
